Good COVID-19 Related Products – 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Favipiravir Intermediate COVID-19 – Ruifu
Good COVID-19 Related Products – 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Favipiravir Intermediate COVID-19 – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Favipiravir (CAS: 259793-96-9) and Related Intermediates:
Favipiravir CAS: 259793-96-9
3,6-Dichloropyrazine-2-carbonitrile CAS: 356783-16-9
3,6-Difluoropyrazine-2-carbonitrile CAS: 356783-28-3
6-Bromo-3-hydroxypyrazine-2-carboxamide CAS: 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS: 55321-99-8
2-Aminopropanediamide CAS: 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS: 13433-00-6
Chemical Name | 3,6-Difluoropyrazine-2-Carbonitrile |
CAS Number | 356783-28-3 |
CAT Number | RF-PI227 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C5HF2N3 |
Molecular Weight | 141.08 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Pale Yellow to Off-White Powder |
Purity | ≥98.0% |
Loss on Drying | ≤1.0% |
Residue on ignition | ≤0.5% |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates; Favipiravir (CAS: 259793-96-9) Intermediate |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
3,6-Difluoropyrazine-2-Carbonitrile CAS: 356783-28-3 is an intermediate of Favipiravir (CAS: 259793-96-9).
Favipiravir (CAS: 259793-96-9) in the treatment of Influenza virus infections. Favipiravir, also known as Favilavir, T705, or Avigan, is a selective inhibitor of viral RNA-dependent RNA polymerase with activity against many RNA viruses, influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated. The mechanism of its actions is thought to be related to the selective inhibition of viral RNA-dependent RNA polymerase. Favipiravir does not inhibit RNA or DNA synthesis in mammalian cells and is not toxic to them. In 2014, favipiravir was approved in Japan for stockpiling against influenza pandemics.
Product detail pictures:
Related Product Guide:
Good COVID-19 Related Products – 3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Favipiravir Intermediate COVID-19 – Ruifu , The product will supply to all over the world, such as: , , ,
-
Excellent quality 5-HmC - 4,6-Dichloropyrimidi...
-
Wholesale Price triphenyl(1-[ethoxycarbonyl]eth...
-
2021 New Style Ropivacaine Hydrochloride Monohy...
-
Factory selling Arabinocytidine - 4-Bromo-2-Py...
-
2021 wholesale price α-Hydroxyisovaleric Acid -...
-
Big Discount Fluoro - 6-Bromoimidazo[1,2-a]pyr...
![5 Stars](https://www.ruifuchemical.com/admin/img/star-icon.png)
![5 Stars](https://www.ruifuchemical.com/admin/img/star-icon.png)